Kimberly J. Popovits has been a part of 10x Genomics, Inc. since March 2020, stepping in as a director and bringing her extensive experience to the board. She previously served as the President and CEO of Genomic Health, Inc., a...
Kimberly J. Popovits has been a part of 10x Genomics, Inc. since March 2020, stepping in as a director and bringing her extensive experience to the board. She previously served as the President and CEO of Genomic Health, Inc., a company she led until its acquisition in 2019. Popovits held pivotal roles in Genentech during her early career, where she honed her skills in marketing and sales. She also has a strong educational background with a B.A. in Business from Michigan State University. Beyond her role at 10x, she has been active on several boards, including Talis Biomedical Corporation and Kiniksa Pharmaceuticals. Interestingly, in 2023, she reported zero compensation at 10x Genomics, which is quite unique for an executive at her level. This focus on performance over pay highlights her commitment to aligning her interests with the company's success. With her deep roots in healthcare and biotechnology, Popovits' insights guide 10x Genomics as it navigates the complex landscape of genetics and molecular biology.